Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Tumor-Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00276783
What this trial is testing

Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases

Who this might be right for
Brain and Central Nervous System TumorsLymphomaMetastatic Cancer
Northwestern University 31
Not applicableStudy completedNCT01811524
What this trial is testing

The Etiology and Progression of Brain Tumors

Who this might be right for
Brain TumorGliomaMeningioma
Tampere University Hospital 2,000
Not applicableNot Yet RecruitingNCT06914427
What this trial is testing

PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique

Who this might be right for
Prostatic NeoplasmsGliomaPARKINSON DISEASE (Disorder)
Xijing Hospital 35
Early research (Phase 1)Looking for participantsNCT06193759
What this trial is testing

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

Who this might be right for
Medulloblastoma, ChildhoodAtypical Teratoid/Rhabdoid Tumor of CNSEmbryonal Tumor With Multilayered Rosettes+3 more
Children's National Research Institute 12
Testing effectiveness (Phase 2)Study completedNCT00033280
What this trial is testing

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 42
Not applicableStudy completedNCT04055688
What this trial is testing

Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas

Who this might be right for
Brain TumorGlioma
H. Lee Moffitt Cancer Center and Research Institute 20
Early research (Phase 1)UnknownNCT00083096
What this trial is testing

Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 30
Testing effectiveness (Phase 2)Study completedNCT00038441
What this trial is testing

Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas

Who this might be right for
GliomaBrain Neoplasms
M.D. Anderson Cancer Center 39
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Not applicableStudy completedNCT04114786
What this trial is testing

3D Printed Mask for GBM and Brain Mets

Who this might be right for
Brain Cancer
University Health Network, Toronto 40
Very early researchStudy completedNCT00890786
What this trial is testing

Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas

Who this might be right for
Newly Diagnosed High-Grade GliomasDiffuse Intrinsic Pontine Glioma
Children's Hospital Medical Center, Cincinnati 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07501156
What this trial is testing

H3K27M-specific Immune Effector Cells Targeting DMG/DIPG

Who this might be right for
Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
Shenzhen Geno-Immune Medical Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT05096481
What this trial is testing

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine GliomaRecurrent Medulloblastoma
Nationwide Children's Hospital 120
Very early researchActive Not RecruitingNCT05045027
What this trial is testing

Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma

Who this might be right for
GliomaMalignant GliomaRecurrent Glioma+1 more
Jonsson Comprehensive Cancer Center 36
Early research (Phase 1)Looking for participantsNCT05298995
What this trial is testing

GD2-CAR T Cells for Pediatric Brain Tumours

Who this might be right for
Brain Tumor, PediatricMedulloblastoma, ChildhoodEmbryonal Tumor+4 more
Bambino Gesù Hospital and Research Institute 54
Not applicableStudy completedNCT02843230
What this trial is testing

Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI

Who this might be right for
Glioblastoma
Massachusetts General Hospital 30
Early research (Phase 1)Study completedNCT00634231
What this trial is testing

A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors

Who this might be right for
Malignant GliomaRecurrent Ependymoma
Candel Therapeutics, Inc. 8
Not applicableStudy completedNCT01878266
What this trial is testing

Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children

Who this might be right for
Pediatric Brain Stem Glioma
Children's Cancer Hospital Egypt 57357 119
Testing effectiveness (Phase 2)Study completedNCT02858895
What this trial is testing

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

Who this might be right for
GlioblastomaGrade IV AstrocytomaGlioblastoma Multiforme+1 more
Medicenna Therapeutics, Inc. 47
Large-scale testing (Phase 3)Ended earlyNCT03149575
What this trial is testing

VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM

Who this might be right for
Glioblastoma MultiformeGlioblastomaGlioma+2 more
DelMar Pharmaceuticals, Inc. 2
Next Page